Patellofemoral Arthroplasty (PFA) prosthesis with asymmetric trochlear component was introduced as an improvement from existing designs for surgical treatment of symptomatic isolated patellofemoral arthritis. The purpose of this study was to evaluate midterm results in patients who underwent PFA procedure using such prosthesis. Our study involved a continuous retrospective cohort of patients who underwent PFA using Journey PFJ with asymmetric trochlear component, performed between June 2007 and October 2018 at a non-designer centre. The Patient Reported Outcome Measures and patient satisfaction questionnaires were collected for final evaluation.Aim
Methods
